My Watchlist

Top Indices

Nasdaq Composite

SPX

My Portfolio

BioRestorative Therapies, Inc. - Common Stock (NQ:BRTX)

1.098 -0.012 (-1.08%)

Streaming Delayed Price Updated: 3:49 PM EST, Nov 21, 2025 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about BioRestorative Therapies, Inc. - Common Stock

< Previous 1 2 3 4 5 6 7 Next >

12 Health Care Stocks Moving In Thursday's Intraday Session ↗

November 20, 2025

Via Benzinga

Traders are paying attention to the gapping stocks in Thursday's session. ↗

November 20, 2025

The market is buzzing with gapping stocks on Thursday. Let's uncover which stocks are experiencing notable gaps during today's session.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

November 20, 2025

Via Benzinga

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

November 19, 2025

Via Benzinga

Earnings Scheduled For November 12, 2025 ↗

November 12, 2025

Via Benzinga

Earnings Outlook For BioRestorative Therapies ↗

August 11, 2025

Via Benzinga

Earnings Preview For BioRestorative Therapies ↗

March 26, 2025

Via Benzinga

BioRestorative (BRTX) Earnings Call Transcript ↗

November 13, 2025

BioRestorative (BRTX) Earnings Call Transcript

Via The Motley Fool

Earnings Outlook For BioRestorative Therapies ↗

November 11, 2025

Via Benzinga

The trading volume of these stocks is deviating from the norm in today's session. ↗

October 28, 2025

Unusual volume stocks are being observed in Tuesday's session.

Via Chartmill

12 Health Care Stocks Moving In Tuesday's Pre-Market Session ↗

October 28, 2025

Via Benzinga

12 Health Care Stocks Moving In Monday's Pre-Market Session ↗

September 22, 2025

Via Benzinga

From Phase 2 Trial Results To Expansion Mode: A Look At BioRestorative's Novel Approach To Treating Chronic Pain

July 16, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

From Phase 2 Trial Results To Expansion Mode: A Look At BioRestorative's Novel Approach To Treating Chronic Pain

July 16, 2025

Via TheNewswire.com

BioRestorative Announces Share Repurchase Program

June 17, 2025

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based

Via PressReach

Earnings Scheduled For August 12, 2025 ↗

August 12, 2025

Via Benzinga

BioRestorative Reports Compelling Preliminary Data for FDA-Fast-Tracked BRTX-100 – an Autologous Stem Cell Therapy to Treat Chronic Lumbar Disc Disease

June 13, 2025

BioRestorative Therapies, Inc. (“BioRestorative,” “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical-stage regenerative medicine company developing stem cell-based

Via PressReach

BioRestorative Welcomes Serial Regenerative Medicine Entrepreneur, Company Builder and Leader, Sandy Lipkins, to BRTX Team

June 10, 2025

BioRestorative Therapies, Inc. (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical stage regenerative medicine innovator focused on stem cell-based

Via PressReach

BioRestorative to Present Major Update on Promising Preliminary Phase 2 BRTX-100 Data at ISSCR 2025

June 09, 2025

BioRestorative Therapies, Inc. (“BioRestorative,” “BRTX” or the “Company”) (NASDAQ:BRTX), a clinical-stage regenerative medicine company developing stem cell-based

Via PressReach

Uncovering Potential: BioRestorative Therapies's Earnings Preview ↗

May 13, 2025

Via Benzinga

Earnings Scheduled For May 14, 2025 ↗

May 14, 2025

Via Benzinga

Leveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative Therapies

April 23, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

Leveraging Stem Cells To Fight Chronic Lower Back Pain And Obesity With BioRestorative Therapies

April 23, 2025

Via TheNewswire.com

BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease

April 16, 2025

Search for the latest press releases from publicly traded companies, private corporations, non-profits and other public sector organizations.

Via NewMediaWire

BioRestorative Therapies Receives FDA Fast Track Approval For BRTX-100 To Treat Chronic Lumbar Disc Disease

April 16, 2025

By Meg Flippin Benzinga

Via TheNewswire.com

Earnings Scheduled For March 27, 2025 ↗

March 27, 2025

Via Benzinga

Which stocks have an unusual volume on Thursday? ↗

February 27, 2025

The trading volume of these stocks is deviating from the norm in today's session.

Via Chartmill

On Tuesday, there are stocks with unusual volume. Let's take a look. ↗

February 25, 2025

In today's session, these stocks are experiencing unusual volume.

Via Chartmill

12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗

December 05, 2024

Via Benzinga

BioRestorative Ends Q3 In ‘Strong’ Financial Position, Reports Positive Data For Its Phase 2 BRTX-100 Chronic Back Pain Trial

November 21, 2024

BioRestorative Ends Q3 In ‘Strong’ Financial Position, Reports Positive Data For Its Phase 2 BRTX-100 Chronic Back Pain Trial

Via News Direct

Topics Intellectual Property

< Previous 1 2 3 4 5 6 7 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.